Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Regeneron Pharmaceuticals
Scientific Title
An Open-Label, Randomized, Phase 3 Clinical Trial of REGN2810 Versus Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Carcinoma